文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

人诱导多能干细胞-神经干细胞与骨髓间充质干细胞联合移植改善急性脊髓损伤的神经炎症反应和促进神经再生。

Combined transplantation of hiPSC-NSC and hMSC ameliorated neuroinflammation and promoted neuroregeneration in acute spinal cord injury.

机构信息

Hebei Medical University-Galway University Stem Cell Research Center, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China.

Hebei Research Center for Stem Cell Medical Translational Engineering, Shijiazhuang, 050017, Hebei Province, China.

出版信息

Stem Cell Res Ther. 2024 Mar 5;15(1):67. doi: 10.1186/s13287-024-03655-x.


DOI:10.1186/s13287-024-03655-x
PMID:38444003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10916262/
Abstract

BACKGROUND: Spinal cord injury (SCI) is a serious clinical condition that has pathological changes such as increased neuroinflammation and nerve tissue damage, which eventually manifests as fibrosis of the injured segment and the development of a spinal cord cavity leading to loss of function. Cell-based therapy, such as mesenchymal stem cells (MSCs) and neural stem cells (NSCs) are promising treatment strategies for spinal cord injury via immunological regulation and neural replacement respectively. However, therapeutic efficacy is rare reported on combined transplantation of MSC and NSC in acute mice spinal cord injury even the potential reinforcement might be foreseen. Therefore, this study was conducted to investigate the safety and efficacy of co-transplanting of MSC and NSC sheets into an SCI mice model on the locomotor function and pathological changes of injured spinal cord. METHODS: To evaluate the therapeutic effects of combination cells, acute SCI mice model were established and combined transplantation of hiPSC-NSCs and hMSCs into the lesion site immediately after the injury. Basso mouse scale was used to perform the open-field tests of hind limb motor function at days post-operation (dpo) 1, 3, 5, and 7 after SCI and every week after surgery. Spinal cord and serum samples were collected at dpo 7, 14, and 28 to detect inflammatory and neurotrophic factors. Hematoxylin-eosin (H&E) staining, masson staining and transmission electron microscopy were used to evaluate the morphological changes, fibrosis area and ultrastructure of the spinal cord. RESULT: M&N transplantation reduced fibrosis formation and the inflammation level while promoting the secretion of nerve growth factor and brain-derived neurotrophic factor. We observed significant reduction in damaged tissue and cavity area, with dramatic improvement in the M&N group. Compared with the Con group, the M&N group exhibited significantly improved behaviors, particularly limb coordination. CONCLUSION: Combined transplantation of hiPSC-NSC and hMSC could significantly ameliorate neuroinflammation, promote neuroregeneration, and decrease spinal fibrosis degree in safe and effective pattern, which would be indicated as a novel potential cell treatment option.

摘要

背景:脊髓损伤(SCI)是一种严重的临床病症,其病理变化包括神经炎症增加和神经组织损伤,最终表现为损伤节段的纤维化和脊髓空洞的发展,导致功能丧失。基于细胞的治疗方法,如间充质干细胞(MSCs)和神经干细胞(NSCs),通过免疫调节和神经替代分别为脊髓损伤提供了有前途的治疗策略。然而,即使可以预见潜在的增强作用,在急性 SCI 小鼠模型中联合移植 MSC 和 NSC 的治疗效果也很少有报道。因此,本研究旨在探讨 MSC 和 NSC 片联合移植入急性 SCI 小鼠模型对损伤脊髓的运动功能和病理变化的安全性和疗效。

方法:为了评估联合细胞的治疗效果,在损伤后立即将 hiPSC-NSC 和 hMSC 联合移植到损伤部位,建立急性 SCI 小鼠模型。术后第 1、3、5 和 7 天以及术后每周使用 Basso 小鼠量表进行后肢运动功能的旷场测试。术后第 7、14 和 28 天收集脊髓和血清样本,检测炎症和神经营养因子。苏木精-伊红(H&E)染色、Masson 染色和透射电镜用于评估脊髓的形态学变化、纤维化面积和超微结构。

结果:M&N 移植减少了纤维化形成和炎症水平,同时促进了神经生长因子和脑源性神经营养因子的分泌。我们观察到 M&N 组损伤组织和空洞面积明显减少,功能明显改善。与 Con 组相比,M&N 组的行为明显改善,特别是肢体协调性。

结论:hiPSC-NSC 和 hMSC 的联合移植可以显著改善神经炎症,促进神经再生,并以安全有效的方式降低脊髓纤维化程度,这将是一种新的潜在细胞治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0010/10916262/2d8309d5d1ef/13287_2024_3655_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0010/10916262/e75116b486e3/13287_2024_3655_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0010/10916262/ffb30857b465/13287_2024_3655_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0010/10916262/857121c49e2b/13287_2024_3655_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0010/10916262/fcddc684b142/13287_2024_3655_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0010/10916262/a106af89132f/13287_2024_3655_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0010/10916262/2d8309d5d1ef/13287_2024_3655_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0010/10916262/e75116b486e3/13287_2024_3655_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0010/10916262/ffb30857b465/13287_2024_3655_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0010/10916262/857121c49e2b/13287_2024_3655_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0010/10916262/fcddc684b142/13287_2024_3655_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0010/10916262/a106af89132f/13287_2024_3655_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0010/10916262/2d8309d5d1ef/13287_2024_3655_Fig6_HTML.jpg

相似文献

[1]
Combined transplantation of hiPSC-NSC and hMSC ameliorated neuroinflammation and promoted neuroregeneration in acute spinal cord injury.

Stem Cell Res Ther. 2024-3-5

[2]
[Effect of removing microglia from spinal cord on nerve repair after spinal cord injury in mice].

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025-6-15

[3]
hiPSC-derived NSCs effectively promote the functional recovery of acute spinal cord injury in mice.

Stem Cell Res Ther. 2021-3-11

[4]
Grafted human-induced pluripotent stem cells-derived oligodendrocyte progenitor cells combined with human umbilical vein endothelial cells contribute to functional recovery following spinal cord injury.

Stem Cell Res Ther. 2024-2-7

[5]
Human umbilical cord mesenchymal stem cell-derived exosomes combined with mouse nerve growth factor can more effectively ameliorate the motor disorder and brain pathological injury in mice with cerebral palsy.

Adv Clin Exp Med. 2025-6

[6]
Association between neural stem/progenitor cells and biomaterials in spinal cord injury therapies: A systematic review and network meta-analysis.

Acta Biomater. 2024-7-15

[7]
Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury.

Cell Transplant. 2012-8-27

[8]
Management of urinary stones by experts in stone disease (ESD 2025).

Arch Ital Urol Androl. 2025-6-30

[9]
Locomotor training for walking after spinal cord injury.

Cochrane Database Syst Rev. 2012-11-14

[10]
Neuroprotective Role of THBS2 in Experimental Spinal Cord Injury Via its Anti-neuroinflammatory and Anti-apoptotic Properties.

Biochem Genet. 2025-6-26

引用本文的文献

[1]
Nanoparticle-mediated sodium butyrate delivery for repairing hypoxic-ischemic brain injury in premature infants.

Mater Today Bio. 2025-3-14

[2]
Multifunctional magneto-electric and exosome-loaded hydrogel enhances neuronal differentiation and immunoregulation through remote non-invasive electrical stimulation for neurological recovery after spinal cord injury.

Bioact Mater. 2025-2-28

[3]
Advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseases.

Stem Cell Res Ther. 2024-12-18

[4]
Self-Healing COCu-Tac Hydrogel Enhances iNSCs Transplantation for Spinal Cord Injury by Promoting Mitophagy via the FKBP52/AKT Pathway.

Adv Sci (Weinh). 2025-1

本文引用的文献

[1]
Human induced neural stem cells support functional recovery in spinal cord injury models.

Exp Mol Med. 2023-6

[2]
Delivery of Induced Neural Stem Cells Through Mechano-Tuned Silk-Collagen Hydrogels for the Recovery of Contused Spinal Cord in Rats.

Adv Healthc Mater. 2023-3

[3]
Coexistence of chronic hyperalgesia and multilevel neuroinflammatory responses after experimental SCI: a systematic approach to profiling neuropathic pain.

J Neuroinflammation. 2022-10-29

[4]
BDNF guides neural stem cell-derived axons to ventral interneurons and motor neurons after spinal cord injury.

Exp Neurol. 2023-1

[5]
Research on Polycaprolactone-Gelatin Composite Scaffolds Carrying Nerve Growth Factor for the Repair of Spinal Cord Injury.

Dis Markers. 2022

[6]
MiR-31 improves spinal cord injury in mice by promoting the migration of bone marrow mesenchymal stem cells.

PLoS One. 2022

[7]
Autophagy-Mediated Inflammatory Cytokine Secretion in Sporadic ALS Patient iPSC-Derived Astrocytes.

Oxid Med Cell Longev. 2022

[8]
Stem cell-based therapy for human diseases.

Signal Transduct Target Ther. 2022-8-6

[9]
A reactive oxygen species-responsive hydrogel encapsulated with bone marrow derived stem cells promotes repair and regeneration of spinal cord injury.

Bioact Mater. 2022-5-9

[10]
Cell-based and stem-cell-based treatments for spinal cord injury: evidence from clinical trials.

Lancet Neurol. 2022-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索